Abstract
P0745 - Subgroup analyses of the phase 3 study of intravesical nadofaragene firadenovec in patients with high-grade, BCG-unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have